4//SEC Filing
Sumner Michael John 4
Accession 0001055726-25-000046
CIK 0001055726other
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 4:08 PM ET
Size
7.3 KB
Accession
0001055726-25-000046
Insider Transaction Report
Form 4
Sumner Michael John
Chief Medical Officer
Transactions
- Exercise/Conversion
Restricted Stock Unit
2025-06-30−2,916→ 0 total→ Common Stock (2,916 underlying) - Exercise/Conversion
Common Stock
2025-06-30+2,916→ 17,850 total
Footnotes (1)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 8,749 restricted stock units was as follows: 2,916 shares vested on June 30, 2023; 2,917 shares vested on June 30, 2024; and 2,916 shares vested on June 30, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
Documents
Issuer
INOVIO PHARMACEUTICALS, INC.
CIK 0001055726
Entity typeother
Related Parties
1- filerCIK 0001936799
Filing Metadata
- Form type
- 4
- Filed
- Jun 30, 8:00 PM ET
- Accepted
- Jul 1, 4:08 PM ET
- Size
- 7.3 KB